Search Form
First, enter a politician or zip code
Now, choose a category
 

Elijah Cummings' Public Statements on Issue: Drugs

Office: U.S. House (MD) - District 7, Democratic
Date Title
Oct. 25, 2017 Afro - The National Opioid Epidemic Demands an Urgent Federal Response
Oct. 2, 2017 Letter to Ms. Tammy Whitcomb, USPS Acting Inspector General - Employee Safety
Sept. 19, 2017 Letter to President Trump - Cummings Leads 50 House Members in Urging President Trump to Negotiate Lower Prices for Lifesaving Drug
June 21, 2017 Letter to the Hon. Donald Trump, President of the United States - Drug Proposal Would Be a "Betrayal" and Grant Pharma's Wish List
May 16, 2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
May 5, 2017 Cummings Statement on Trump Administration Memo Proposing Cuts to ONDCP
April 4, 2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices
March 29, 2017 Schakowsky, Cummings, DeLauro, and Welch Introduce Comprehensive Bill to Address Drug Pricing
March 29, 2017 Letter to the Hon. Chariman John Culberson, Hon. Chairman Tom Cole, Hon. Chairman Tom Graves, Hon. Ranking Member Jose Serrano, Hon. Ranking Member Rosa DeLauro, Hon. Ranking Member Mike Quigley of the House Committee on Appropriations - Bipartisan Heroin Task Force Calls for Funding of the Comprehensive Addiction and Recovery Act
March 15, 2017 Letter to Dr. Stephen Ostroff, Acting Commissioner of US Food and Drug Administration - Information Request on FDA approval of new Deflazacort Drug
March 8, 2017 Cummings and Welch Propose Medicare Drug Negotiation Bill in Meeting With President
March 7, 2017 Cummings to Meet with President on Lowering Prescription Drug Prices
Feb. 28, 2017 Affordable and Safe Prescription Drug Importation Act Introduced to Help Lower Skyrocketing Cost of Medicine
Feb. 16, 2017 Cummings Issues Statement in Response to President Trump's Press Conference
Feb. 13, 2017 Letter to Jeffrey S. Aronin, Chairman and Chief Executive Officer of Marathon Pharmaceuticals, LLC - Information Request on Pricing Plan for Emflaza (Deflazacort)
Dec. 16, 2016 Letter to Gary Ruckelshaus, Vice President and General Counsel of Heritage Pharmaceuticals Inc. - Information Request Regarding Alleged Price Fixing of Certain Drugs
Nov. 3, 2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States and the Hon. Edith Ramirez, Chairwoman of the Federal Trade Commission - Request to Investigate Cost of Diabetes Products
Sept. 30, 2016 Letter to Ms. Heather Bresch, Chief Executive Officer of Mylan - Concerns About Mylan's EpiPen Price HIke
Sept. 21, 2016 Hearing of the House Oversight and Government Reform Committee - Ranking Member's Opening Statement on "Reviewing the Rising Price of EpiPens"
Sept. 13, 2016 Letter to the Honorable Paul Ryan, Speaker of the House and the Honorable Nancy Pelosi, Minority Leader of the House - Calling for Budget Anomalies to Address Opioid Epidemic
July 7, 2016 Letter to the Honorable Robert M. Califf, Commissioner of the Food and Drug Administration - Condemning AstraZeneca for Putting Profits Over People
May 17, 2016 WMAR - New Federal Effort to Address Heroin and Prescription Drug Abuse
May 16, 2016 The Baltimore Sun - Federal Lawmakers Tout House Opioid Abuse Bills
May 16, 2016 WBALTV - Maryland Delegation Rallies for More Addiction-Related Treatment
May 16, 2016 Baltimore Congressional Delegation Announce New Federal Effort to Reduce Opioid Abuse in Maryland and Across America
May 12, 2016 Kennedy Joins House Coalition Pushing for Opioid Response Funding
May 12, 2016 Members from Areas Hard Hit by Drug Crisis Introduce Bill to Provide More Than $1 Billion to Combat Epidemic
March 28, 2016 Letter to the Honorable Sylvia M. Burwell, Secretary of Health and Human Services and Francis Collins, Director of National Institutes of Health - Act Now on Drug Affordability
March 22, 2016 Hearing of the House Oversight and Government Reform Committee - Opening Statement of Rep. Cummings, Hearing on "American's Heroin and Opioid Abuse Epidemic"
Feb. 2, 2016 Cummings Praises President Obama's Proposal to Address Prescription Opioid and Heroin Abuse
Sept. 9, 2015 Hearing of the House Oversight and Government Reform Committee - Violence on the Border: Keeping U.S. Personnel Safe
Aug. 17, 2015 Cummings Applauds Obama Administration for Awarding Millions in Federal Grants to Fund Heroin Response Strategy
Aug. 17, 2015 Hoyer, Maryland Congressional Delegation Announce Federal Funding To Combat Heroin Trafficking In Washington/Baltimore Region
July 29, 2015 Letter to Stephanie Rawlings-Blake, President of the United States Conference of Mayors, and Sallie Clark, President of the National Association of Counties - Naloxone Cost and Access
July 27, 2015 Mikulski, Cardin, Cummings Announce More than $815,000 in Federal Funds to Treat Drug Addiction in Maryland
July 23, 2015 Cummings Applauds Maryland AG for Moving Aggressively to Combat Drug Overcharging
July 13, 2015 Letter to John Kickenlooper, Governor of Colorado, Nancy Wyman, Lieutenant Governor of Connecticut, and Marty Jackley, Attorney General of South Dakota - Reduction in the Cost of Naloxone
July 10, 2015 MONDAY: Cummings to Speak at Press Conference on Efforts to Combat Heroin Epidemic in Maryland
March 24, 2015 Letter to Chairman Ander Crenshaw and Ranking Member Jose E. Serano, Subcommittee on Financial Services and General Government House Committee on Appropriations - Bipartisan Call to Stop Drug Trafficking
March 2, 2015 Letter to Jack Zhang, CEO of Amphastar Pharmaceuticals, Incorporated - Price Increases for Drug that Police Use to Treat Overdoses
Feb. 25, 2015 Conyers-Cummings-Lowey-Serrano Issue Statement Supporting D.C.'s Legal Interpretation of Initiative 71
Nov. 20, 2014 Sanders and Cummings Introduce Legislation to Require Drug Company Rebates for Generic Drugs
Nov. 20, 2014 Hearing of the Primary Health and Aging Subcommittee of the Senate Health, Education, Labor, and Pensions Committee - Why Are Some Generic Drugs Skyrocketing In Price?
Nov. 11, 2014 Congressional Panel to Probe Generic Drug Price Hikes
Oct. 2, 2014 Letter to Jeffrey Aronin, Chairman and CEO of Marathon Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Arthur Bedrosian, President and CEO of Lannett Company - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Brian Lortie, President at Endo International PLC - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Erez Vigodman, President and CEO of Teva Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Glazer, President and CEO of Heritage Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Umang Vohra, Executive Vice President of Dr. Reddy's Laboratories LTD - Investigating Staggering Price Increases for Generic Drugs
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top